2026 NPPES data Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician NPI 1386639565 MD
Verify on CMS →

SCOTT BOYD, MD

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician in FORT WAYNE, Indiana. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
919
Medicare Part D claims · 253 beneficiaries · Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician avg: 611
Generic prescribing
61%
generic claims · 39% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$720.84
13 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

SCOTT BOYD, MD filed 919 Medicare Part D claims in 2023 as a Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician in FORT WAYNE, Indiana, prescribing 61% generic.

919
Part D claims, 2023
61%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

SCOTT BOYD, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

919 Top 25% higher than 75% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). This entry sits in this band. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

SCOTT BOYD, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about SCOTT BOYD, MD?

Quality data not reported

NPI registry status

Active

Issued 09/14/2005

NPI 1386639565

Primary specialty

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician

Niche

568 US NPIs in this specialty

Medicare Part D claims

919 50% vs specialty avg

2023 prescription claims

Specialty avg: 611

Specialty distribution in Indiana

How Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician compares to other specialties among Indiana providers

Indiana providers

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician share within Indiana

1. Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician share within Indiana

Specialty board-certification context

Estimated specialty board-certified rate — Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician ABMS/AOA estimate

Est. board-certified rate (Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SCOTT BOYD, MD appears in the CMS NPPES registry as a Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician provider holding MD credentials at 11123 PARKVIEW PLAZA DR STE 102, FORT WAYNE, IN, 46845, with a listed phone of (260) 425-5240. NPI 1386639565 was issued on 09/14/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BOYD most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 919 prescription claims written by this provider, covering 253 Medicare beneficiaries and totaling roughly $254K in drug spend, split 39% brand-name and 61% generic by claim count, with an opioid prescribing rate of 7.5%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician is a narrow specialty nationwide, with 568 enrolled providers across 49 states and an average of 611 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

11123 PARKVIEW PLAZA DR STE 102
FORT WAYNE, IN 46845

Provider Details

NPI 1386639565
Specialty Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician
Credentials MD
Gender Male
NPI Issued 09/14/2005

Hospital and facility affiliations

Facilities where SCOTT BOYD, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

PARKVIEW HEALTH SYSTEM INC
FORT WAYNE, IN

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SCOTT BOYD, MD. Source: openpaymentsdata.cms.gov.

Total received

$721

Largest payer

Axonics, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

SCOTT BOYD, MD — brand share 39.0%
Specialty average (est.)

39% brand-name claims vs 61% generic, on 919 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

919
Total Claims
$254K
Total Drug Cost
253
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,351
Total Day Supply
32,464
Brand vs Generic
39% brand / 61% generic
Brand Drug Cost
$233K
Generic Drug Cost
$22K
Opioid Claims
69 (7.5% rate)
Antibiotic Claims
249

Patient Demographics

Average Patient Age
73.4 years
Avg HCC Risk Score
1.10
Gender Split
100% female / 0% male
Age Distribution
<65: 18, 65-74: 115, 75-84: 94, 85+: 26

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What SCOTT BOYD, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Myrbetriq
Mirabegron
200
Nitrofurantoin Mono-Macro
Nitrofurantoin Monohyd/M-Cryst
92
Gemtesa
Vibegron
84
Ciprofloxacin Hcl
72
Estradiol
65
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
59
Cephalexin
31
Trospium Chloride
25
Solifenacin Succinate
21
Fluconazole
19

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician Overview

How SCOTT BOYD, MD fits within the Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician landscape nationally.

568
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician Providers in US
49
States with Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician
611
Avg Claims per Provider

SCOTT BOYD, MD's 919 claims are above the specialty average of 611.

Nearby Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician Providers in Indiana

Other clinicians with the same primary specialty enrolled in Indiana, drawn from the same CMS NPPES roster as BOYD.

Compare Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SCOTT BOYD, MD's specialty?
SCOTT BOYD, MD specializes in Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician and practices in FORT WAYNE, Indiana. Credentials: MD.
How much does SCOTT BOYD, MD prescribe under Medicare Part D?
In 2023, SCOTT BOYD, MD wrote 919 Medicare Part D claims totaling $254K in drug costs for 253 beneficiaries.
Where is SCOTT BOYD, MD located?
SCOTT BOYD, MD is located at 11123 PARKVIEW PLAZA DR STE 102, FORT WAYNE, IN, 46845. Phone: (260) 425-5240.
What is SCOTT BOYD, MD's NPI number?
SCOTT BOYD, MD's National Provider Identifier (NPI) is 1386639565, issued on 09/14/2005.
Does SCOTT BOYD, MD prescribe more brand-name or generic drugs?
SCOTT BOYD, MD's prescribing is 39% brand-name and 61% generic drugs by claim count, with $233K in brand drug costs.
Does SCOTT BOYD, MD prescribe opioids?
Yes, SCOTT BOYD, MD had 69 opioid claims in 2023 with an opioid prescribing rate of 7.5%.
How many Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician providers are there in the US?
There are 568 Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician providers across 49 states in the US. The average Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician provider writes 611 Medicare Part D claims per year.
What drugs does SCOTT BOYD, MD prescribe most often?
Based on 2023 Medicare Part D data, SCOTT BOYD, MD's most frequently prescribed drugs include Myrbetriq, Nitrofurantoin Mono-Macro, Gemtesa. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SCOTT BOYD, MD accept Medicare?
SCOTT BOYD, MD appears in CMS Medicare data with 919 Part D claims and 253 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SCOTT BOYD, MD's credentials?
SCOTT BOYD, MD's NPI is 1386639565 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology